Breaking News
Sort by:
Top Post
Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine
Google Cloud has announced two new AI-powered life sciences solutions to accelerate drug discovery and […]
Exscientia Accelerates COVID-19 Drug Discovery Using AI
Exscientia has received a grant from the Bill & Melinda Gates Foundation and Gates Philanthropy […]
Univercells Technologies and VectorBuilder Announce Strategic Partnership for Optimized Custom Viral Vector Production
Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production, has […]
Genoskin Launches ISR Platform®, the First Human Skin Ex Vivo Platform to Study Injection Site Reactions (ISR)
Genoskin, a biotechnology company that provides transformative platforms and tools leveraging human skin to test […]
Sosei Heptares and InveniAI Enter a Multi-target AI-powered and GPCR-focused Drug Discovery Collaboration
Sosei Group Corporation (“the Company”) (TSE: 4565), the world leader in GPCR-focused structure-based drug design and […]
New Soliqua ® Data Shows Improved Blood Sugar Control Without Weight Gain Versus Premixed Insulin
A new study of Soliqua (insulin glargine 100 Units/mL and lixisenatide, iGlarLixi) met its two […]
Vida Ventures Closes $825 Million Vida III Fund to Advance Transformative Biomedical Innovations
Vida Ventures (“Vida”), a next-generation life sciences venture firm, announced today the closing of Vida Ventures […]
EQRx and Exscientia Enter Strategic Drug Creation, Development, and Commercialization Collaboration to Accelerate the Advancement of New World-Class Medicines
EQRx, a company committed to developing and delivering important new medicines to patients at radically […]
Recursion Announces Multi-Year Collaboration with Mila for Tech-Enabled Drug Discovery
Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, […]
Ping An Makes Breakthrough in Artificial Intelligence-Driven Drug Research
Research by Ping An Healthcare Technology Research Institute and Tsinghua University has led to a […]
HealthTech: Healing Health Care’s Ailments
By Frédérique Carrier, Head of Investment Strategy, RBC Wealth Management With bloated costs and gaps […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more